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Quantification of regional left ventricular function in Q wave
and non-Q wave dysfunctional regions by tissue Doppler
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Objective: To quantify regional left ventricular (LV) function and contractile reserve in Q wave and non-Q
wave regions in patients with previous myocardial infarction.
Design: An observational study.
Setting: Tertiary care centre.
Patients: 81 patients with previous myocardial infarction and depressed LV function.
Interventions: All patients underwent surface ECG at rest and pulsed wave tissue Doppler imaging at rest
and during low dose dobutamine infusion. The left ventricle was divided into four major regions (anterior,
inferoposterior, septal, and lateral). Severely hypokinetic, akinetic, and dyskinetic regions on two
dimensional echocardiography at rest were considered dysfunctional.
Main outcome measures: Regional myocardial systolic velocity (Vs) at rest and the change in Vs during
low dose dobutamine infusion (DVs) in dysfunctional regions with and without Q waves on surface ECG.
Results: 220 (69%) regions were dysfunctional; 60 of these regions corresponded to Q waves and 160
were not related to Q waves. Vs and DVs were lower in dysfunctional than in non-dysfunctional regions
(mean (SD) Vs 6.2 (1.9) cm/s v 7.1 (1.7) cm/s (p , 0.001), and DVs 1.9 (1.9) cm/s v 2.6 (2.5) cm/s
(p = 0.009), respectively). There were no significant differences in Vs and DVs among dysfunctional
regions with and without Q waves (Q wave regions: Vs 6.2 (1.8) cm/s, DVs 1.6 (2.2) cm/s; non-Q wave
regions: Vs 6.3 (1.9) cm/s, DVs 2.0 (2.0) cm/s).
Conclusions: Quantitative pulsed wave tissue Doppler demonstrated that, among dysfunctional regions,
Q waves on the ECG do not indicate more severe dysfunction, and myocardial contractile reserve is
comparable in Q wave and non-Q wave dysfunctional myocardium.
T
raditionally, the classification of myocardial infarctions
as transmural or subendocardial has been based on the
presence or absence of Q waves on surface ECG. Even
nowadays, chronic pathological Q waves are often considered
to represent myocardial regions with more extensive damage
than in dysfunctional non-Q wave related regions. However,
several studies have shown a poor correlation between Q
waves on the ECG and histopathological findings in patients
with a healed myocardial infarction.1 2 Nuclear and echocar-
diographic techniques used for the detection of viable
myocardium have shown that Q wave related regions may
contain hibernating myocardium—that is, dysfunctional but
viable tissue.3–5 Moreover, disappearance of Q waves and
improvement of regional left ventricular (LV) function have
been observed after myocardial revascularisation.6–8
Quantitative information on regional LV function and
contractile reserve in Q wave and non-Q wave dysfunctional
regions is lacking. Accordingly, the aim of this study was to
quantify myocardial function at rest and contractile reserve
during low dose dobutamine infusion by pulsed wave tissue
Doppler imaging (TDI) in Q wave and non-Q wave dysfunc-
tional regions in patients with chronic coronary artery disease
and reduced LV function.
METHODS
Study population
The patient population consisted of 81 consecutive patients
with healed Q wave myocardial infarction and ischaemic
cardiomyopathy (left ventricular ejection fraction (LVEF)
(40% and symptoms of congestive heart failure). Patients
with left bundle branch block, pacemaker rhythm, primary
cardiomyopathy or significant valvar disease were not
included. All patients underwent resting surface ECG to
identify Q wave and non-Q wave regions. Two dimensional
echocardiography at rest and during low dose dobutamine
infusion (10 mg/kg/min) was performed to assess regional LV
function and myocardial contractile reserve. Pulsed wave TDI
at rest and during low dose dobutamine infusion was used to
quantify regional wall motion velocity. The LVEF was
assessed by radionuclide ventriculography. The hospital
medical ethics committee approved the protocol and all
patients gave informed consent.
ECG analysis
Two experienced observers blinded to any other data and
using the Selvester QRS screening criteria for Q wave
myocardial infarction evaluated the surface ECGs.
Accordingly, Q waves were classified as pathological if the
following criteria were met: (1) Q wave > 30 ms in aVF; (2)
Q wave > 40 ms in I and aVL; (3) Q wave > 40 ms in two or
more of V4–V6; (4) R wave > 40 ms in V1; (5) any Q wave in
V2; and (6) R wave ( 0.1 mV and ( 10 ms in lead V2.9 10
Pathological Q waves were assigned to four LV regions:
anterior (preserved R wave in V1 and pathological Q wave in
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: LV, left ventricular; LVEF, left ventricular ejection
fraction; TDI, tissue Doppler imaging; Vs, systolic ejection velocity
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one or more of leads V22V5); septal (pathological Q waves in
V1, V2, or V3); lateral (pathological Q wave in more than one
of leads I, aVL, or V6); or inferoposterior (pathological Q
wave in more than one of leads II, III, aVF).4
Two dimensional echocardiography
A commercially available imaging system equipped with a
1.8 MHz transducer and second harmonic imaging to
optimise endocardial border visualisation was used to record
two dimensional echocardiograms (Hewlett Packard Sonos
5500, Andover, Massachusetts, USA). Four standard views
were recorded and two experienced reviewers visually scored
the digitised echocardiograms. Regional wall motion and
systolic wall thickening were scored using a 16 segment
model and a five point grading scale: 1 is normal, 2 is mildly
hypokinetic, 3 is severely hypokinetic, 4 is akinetic, 5 is
dyskinetic. The 16 segment model was converted to
correspond to the four major regions (anterior, inferoposter-
ior, septal, and lateral). A region was considered dysfunc-
tional if one or more segments in the region were severely
hypokinetic, akinetic, or dyskinetic on two dimensional
echocardiography.
Tissue Doppler imaging
Pulsed wave TDI was performed with the same system used
for the assessment of wall motion abnormalities, with a pulse
repetition frequency of 45–60 KHz. A sample volume of
4 mm3 was used. Myocardial velocity was sampled in apical
views (posterior septum, anterior septum, and lateral,
inferior, anterior, and posterior walls) close to the mitral
annulus and during a minimum of five consecutive beats to
minimise the variability induced by respiration. The depth of
the sample volume of every wall was kept constant during
dobutamine stress echocardiography to make sure that LV
myocardium was sampled close to the mitral annulus.
The Doppler velocity profiles and ECG tracings were
simultaneously stored on optical disk. All the measurements
were performed off line with a computer assisted drawing
system. The velocity values (cm/s) were obtained on
calibrated still frames by manually measuring the distance
between the zero baselines and the peak Doppler profile of
the ejection phase in reference to the ECG. Cardiac cycles
with extrasystolic or post-extrasystolic beats or rhythm
disturbance were excluded. Recordings and measurements
were made at baseline and at low dose (10 mg/kg/min)
dobutamine infusion. The myocardial walls were related to
the four major LV regions (anterior, septal, lateral, infero-
posterior) by calculating the mean Doppler velocities of the
anterior and posterior septum (septal region) and of the
inferior and posterior wall (inferoposterior region). As
described previously, a cut off value of > 1 cm/s in systolic
ejection velocity (Vs) at low dose dobutamine infusion was
used to define viability of dysfunctional regions.11
Radionuclide ventriculography
To assess the LVEF, radionuclide ventriculography at rest was
performed in all patients. A small field of view gamma
camera system (Orbiter, Siemens, Erlangen, Germany) was
used oriented in a 45˚left anterior oblique position with a 5–
10˚ caudal tilt. After injection of Tc-99m (740 MBq), radio-
nuclide ventriculography was performed at rest with the
patient in supine position. The LVEF was calculated by
standard methods (Odyssey VP, Picker, Cleveland, Ohio, USA).
Statistical analysis
All continuous data are expressed as mean (SD) and
percentages are rounded. Continuous variables were com-
pared using Student’s t test for unpaired samples. Differences
between proportions were compared using the x2 test. A
value of p , 0.05 was considered significant.
RESULTS
Study patients had a mean age of 61 (10) years (range 43–78
years). Mean LVEF was 32 (9)% (range 10–40%). Table 1
shows the baseline patient characteristics.
ECG results
An abnormal Q wave pattern was present in 89 regions; 27
(30%) of them were anterior, 27 (30%) inferoposterior, 19
(22%) septal, and 16 (18%) lateral regions. On average, the
patients had 1.1 (0.5) regions associated with a Q wave
pattern on the ECG.
Wall motion analysis
A total of 320 of 324 (99%) regions were analysed both by
two dimensional echocardiography and by pulsed wave TDI.
Assessment of myocardial wall motion by two dimensional
echocardiography showed that 220 (69%) regions were
dysfunctional (severely hypokinetic, akinetic, or dyskinetic).
Among them, 60 (27%) regions were Q wave related: 16
(27%) anterior, 17 (28%) inferoposterior, 13 (22%) septal,
and 14 (23%) lateral regions. Figure 1 illustrates the
distribution of myocardial regions.
Tissue Doppler imaging
The mean Vs of dysfunctional regions was 6.2 (1.9) cm/s and
of non-dysfunctional regions was 7.1 (1.7) cm/s (p , 0.001).
Figure 2 presents the mean systolic TDI velocities at baseline
and at low dose dobutamine infusion. Vs increased sig-
nificantly at low dose dobutamine infusion in both Q wave
and non-Q wave dysfunctional regions (Q wave regions: from
6.2 (1.8) cm/s at rest to 7.8 (2.9) cm/s at low dose
(p , 0.001); non-Q wave regions: from 6.3 (1.9) cm/s at rest
to 8.3 (2.8) cm/s a low dose; p , 0.001). There was no
significant difference in Vs at rest and at low dose
dobutamine between Q wave related and non-Q wave related
dysfunctional regions (baseline 6.2 (1.8) cm/s v 6.3 (1.9) cm/s;
p = 0.948; low dose dobutamine infusion 7.8 (2.9) cm/s v
8.3 (2.8) cm/s; p = 0.268 in Q wave and non-Q wave
regions, respectively).
The increase of Vs from baseline to low dose dobutamine
infusion (DVs) was higher in non-dysfunctional regions (2.6
(2.5) cm/s v 1.9 (1.9) cm/s in dysfunctional regions;
p = 0.009). No difference in DVs was found between Q
Table 1 Baseline clinical characteristics
Male sex 69 (85%)
Age (years) 61 (10)
LVEF (%) 323 (10)8
Diabetes mellitus* 6 (7%)
Hypercholesterolaemia 36 (44%)
Systemic hypertension` 28 (35%)
Current smoking 30 (37%)
History of angina 50 (62%)
Previous revascularisation
PTCA 13 (16%)
CABG 20 (35%)
Medication
b Blockers 40 (49%)
ACE inhibitors 51 (63%)
Data are presented as number (%) of patients or mean (SD).
*Patients receiving oral antidiabetic agents or insulin.
Defined as a total cholesterol >6.4 mmol/l or treatment with lipid
lowering medication.
`Defined as blood pressure >140/90 mm Hg or treatment with
antihypertensive medication.
ACE, angiotensin converting enzyme; CABG, coronary artery bypass
grafting; LVEF, left ventricular ejection fraction; PTCA, percutaneous
transluminal coronary angioplasty.
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wave and non-Q wave related regions (1.6 (2.2) cm/s v 2.0
(2.0) cm/s, respectively; p = 0.129). Table 2 shows the TDI
velocities found in each of the four myocardial regions.
Considering an increase in baseline Vs of > 1 cm/s at low dose
dobutamine infusion as the cut off value to define viability, 60%
and 73% of Q wave and non-Q wave dysfunctional regions,
respectively, were viable (p = 0.104) (fig 1).
DISCUSSION
In the present study, pulsed wave TDI, a relatively new
echocardiographic technique with high temporal resolution
for the quantification of myocardial wall motion velocity, was
used. The results show that Q wave regions on surface ECG
do not necessarily indicate more advanced myocardial
dysfunction than do dysfunctional non-Q wave regions.
Although Vs was found to be significantly higher in non-
dysfunctional regions, the comparison between dysfunctional
Q wave and dysfunctional non-Q wave related regions
showed no difference, both at rest and at low dose
dobutamine infusion. Furthermore, when a cut off value of
DVs> 1 cm/s from rest to low dose dobutamine infusion was
used to discriminate viable from non-viable dysfunctional
regions, the prevalence of myocardial viability was similar in
regions with and without Q waves.
Comparison with previous studies
The detection of viable tissue in patients with ischaemic
cardiomyopathy is considered a critical issue affecting
patients’ quality of life and survival. The decision for
revascularisation is influenced by the presence or absence
of viability. Several studies have reported the beneficial effect
of revascularisation on LV function and on survival in
patients with LV dysfunction and a substantial amount of
viable myocardium.7 8 12–14 Various non-invasive techniques
(mainly nuclear and echocardiographic) have been used to
assess myocardial viability in patients with LV dysfunction
caused by chronic coronary artery disease. For many years, Q
waves in dysfunctional regions were believed to reflect
irreversibly scarred myocardial tissue and Q waves were
associated with more severely damaged myocardium.
However, there is some evidence from histopathological
studies that residual viable tissue may be present in
dysfunctional regions with Q waves on the ECG. Moreover,
non-invasive imaging techniques have shown signs of viable
myocardium in Q wave infarcted regions. The proportion of
viable tissue found in patients with Q wave myocardial
infarction varies between studies that used positron emission
tomography to assess viability, ranging from 36–68%.3–5
Q waves represent the initial 40 ms of depolarisation.
When a region is depolarised after this time period, as is the
case for basal myocardial regions, Q waves are not produced
on ECG. In addition, there are many Q wave equivalent ECG
signs that can be missed and be considered to be a lack of
Figure 1 Distribution of myocardial
regions in study patients.
Figure 2 Myocardial systolic velocities in Q wave and non-Q wave
dysfunctional regions.
Table 2 Pulsed wave myocardial systolic velocities of
Q wave and non-Q wave dysfunctional regions at rest
and during low dose dobutamine infusion
Region Q wave regions
Non-Q wave
regions p Value
Systolic velocity at rest (cm/s)
Anterior 6.6 (1.9) 6.2 (2.0) NS
Inferoposterior 6.2 (1.8) 6.6 (2.0) NS
Septal 5.3 (1.2) 5.9 (1.8) NS
Lateral 6.7 (2.0) 6.3 (1.8) NS
Mean 6.2 (1.8) 6.3 (1.9) NS
Systolic velocity at low dose dobutamine (cm/s)
Anterior 7.8 (3.5) 8.6 (2.9) NS
Inferoposterior 8.5 (2.5) 8.6 (2.9) NS
Septal 6.7 (2.0) 7.4 (2.4) NS
Lateral 8.2 (3.1) 8.8 (2.9) NS
Mean 7.8 (2.9) 8.3 (2.8) NS
Increase in systolic velocity from rest to low dose (cm/s)
Anterior 1.1 (2.0) 2.4 (2.6) NS
Inferoposterior 2.2 (1.7) 1.9 (1.6) NS
Septal 1.4 (1.7) 1.5 (1.4) NS
Lateral 1.5 (1.7) 2.4 (2.2) NS
Mean 1.6 (2.2) 2.0 (2.0) NS
Data are presented as mean (SD).
NS, not significant.
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Q waves. The present data show that Q waves do not
necessarily represent a transmural infarction; residual viable
tissue was present in a high proportion of dysfunctional
regions with Q waves on surface ECG.
Quantitative information on regional LV function and
contractile reserve in Q wave and non-Q wave dysfunctional
regions is lacking. Therefore, this study quantified regional
LV function at rest and contractile reserve during infusion of
low dose dobutamine in Q wave and non-Q wave dysfunc-
tional regions. In accordance with the previous studies that
assessed myocardial viability in Q wave regions, we found
viable tissue in 60% of Q wave related regions when an
increase in Vs of > 1 cm/s at low dose dobutamine challenge
was used to define viability. Dysfunctional non-Q wave
regions were more often viable (73%), although the
difference did not reach significance.
Assessment of viabili ty by TDI
Dobutamine stress echocardiography can be used to assess
the presence of viable myocardium by showing an improve-
ment in myocardial wall motion during low dose dobutamine
challenge.6 The presence of increased wall thickening at low
dose dobutamine infusion with subsequent worsening during
higher rates of infusion (biphasic response) has been found
to increase the test’s sensitivity for the detection of viability.15
However, the assessment of myocardial wall motion with
dobutamine infusion is subjective, showing low sensitivity to
detect minor alterations in myocardial wall motion.
Pulsed wave TDI has the ability to quantify myocardial wall
motion velocities.16 17 Several factors can influence TDI
measurements, such as the translational and rotational
motion of the heart within the thorax, as well as the angle
of incidence of the ultrasound beam relative to the axis of
myocardial longitudinal movement. By assessing myocardial
velocities from the apical views, the effect of translation and
rotation of the heart on the measurement of myocardial
velocities is minimised. In addition, the apex acts as a fixed
reference point facilitating the assessment of contraction and
relaxation in the axial plain without the need for angle
correction.18 A possible limitation in the evaluation of TDI
results may be tethering between adjacent regions that can
influence its ability to localise differences in myocardial
velocity. To avoid this effect, tissue Doppler tracings were
obtained with the sample positioned near the mitral annulus
to assess the vectorial sum of contraction velocities of the
longitudinally oriented myocardial fibres between the base
and the apex.19
Pulsed wave TDI is a feasible and relatively inexpensive
technique that can increase the sensitivity of the dobutamine
stress test, having at the same time a specificity that is
comparable with that of the dobutamine stress test.11 20 21
Hence, pulsed wave TDI can be used in clinical practice to
provide additional information on viability, especially in
regions where visual delineation of endocardium by two
dimensional echocardiography is suboptimal or interpreta-
tion of wall motion is difficult.
Study limitations
In the current study, TDI was used to assess regional LV
function at rest and during low dose dobutamine infusion.
However, the results of functional outcome after revascular-
isation were not examined. Secondly, although the left
ventricle was divided into four major regions to compare
ECG with echocardiographic data, misalignment may have
influenced the study results.22 23 Lastly, patients who under-
went previous revascularisation were included in the study.
Myocardial revascularisation might have influenced the
presence and the number of Q waves, as well as the presence
of viable myocardium. Nevertheless, the time interval
between revascularisation and the current study was more
than a year in all patients.
Conclusions
Quantitative TDI showed comparable wall motion velocities
at rest and during low dose dobutamine infusion in
dysfunctional regions with and without Q waves. Among
dysfunctional regions, Q waves on the ECG do not indicate
more severe dysfunction and myocardial contractile reserve
was comparable in Q wave and non-Q wave dysfunctional
myocardium. Hence, in patients with LV dysfunction caused
by chronic coronary artery disease, viability should be
assessed non-invasively irrespective of the presence of Q
waves on the surface ECG.
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Spontaneous coronary artery dissection in a pre-menopausal woman presenting with transient ST
segment elevation
A
45 year old, pre-menopausal woman,
without any known risk factors for
coronary artery disease, presented in
the emergency department with acute onset
of chest pain. The ECG showed transient ST
segment elevation of 3 mm in leads V32V6.
Although creatine kinase (CK) and CK-MB
were not increased, troponin I elevation
(3.1 ng/ml) was observed during hospitalisa-
tion in the coronary care unit. Because of the
transient appearance of the ST segment
elevation, thrombolysis was not adminis-
tered. Instead the patient received nitrates,
b blockers, aspirin, and heparin and her
symptoms were controlled.
Coronary angiography showed a long
segment dissection extending from the prox-
imal left anterior descending artery (LAD) to
the distal segment of the vessel (panel A).
Contrast media entrapment was observed at
the origin of the dissection (panel B). The
left ventriculogram showed pronounced
hypokinesia of the anterolateral and apical
segments with a calculated ejection fraction
of 40%.
Because of the transient ST segment
elevation, there was a high probability of
coronary spasm or spontaneous dissection of
the LAD, as the ECG changes were present in
the anterior leads. Therefore, a thrombolytic
agent was not administered and the conser-
vative approach was preferred.
E Tsiamis
K Toutouzas
C Stefanadis
ktoutouz@otenet.gr
(A) In left anterior oblique projection the origin
(upper arrow) of the dissection is observed in
the proximal segment of left anterior
descending coronary artery (LAD). The flap of
the dissection ends at the distal segment of the
LAD (lower arrow). The dissection is not flow
limiting. The left circumflex artery is free of
disease. (B) In anteroposterior projection the
dissection is clearly observed. The flap of the
dissection extends from the proximal (upper
arrow) to the distal (lower arrow) segment of
the LAD. (C) Immediately after injection of
contrast media entrapment of contrast media
(arrow) was observed at the proximal segment
of the LAD, just distal to the origin of the flap of
the dissection.
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